Disc Medicine amends Hercules loan agreement, draws down $30 million tranche

Hercules Capital, Inc.
Disc Medicine, Inc.

Hercules Capital, Inc.

HTGC

0.00

Disc Medicine, Inc.

IRON

0.00
  • Disc Medicine entered a first amendment to its 2024 loan agreement with Hercules Capital to extend availability for future advances.
  • Drawdown of USD 30 million under the Tranche 1-B Advance.
  • Split the existing USD 50 million Tranche 1-C Advance into USD 25 million available through March 31, 2027, USD 25 million Tranche 1-D through April 30, 2027.
  • Extended draw periods for the Tranche 2 Advance to Dec. 15, 2027, Tranche 3 Advance to June 30, 2028.
  • Revised minimum cash covenant to start testing on July 1, 2028.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Disc Medicine Inc. i published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-290542), on June 30, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.